Below are the most recent publications written about "Electrocardiography" by people in Profiles.
-
Sangha V, Dhingra LS, Aminorroaya A, Croon PM, Sikand NV, Sen S, Martinez MW, Maron MS, Krumholz HM, Asselbergs FW, Oikonomou EK, Khera R. Identification of hypertrophic cardiomyopathy on electrocardiographic images with deep learning. Nat Cardiovasc Res. 2025 Aug; 4(8):991-1000.
-
Gaspari R, Lindsay R, She T, Acuna J, Balk A, Bartnik J, Baxter J, Clare D, Caplan RJ, DeAngelis J, Filler L, Graham P, Hill M, Hipskind J, Joseph R, Kapoor M, Kummer T, Lewis M, Midgley S, Nalbandian A, Narveas-Guerra O, Nomura J, Sanjeevan I, Scheatzle M, Schnittke N, Secko M, Soucy Z, Stowell JR, Theophanous RG, Tozer J, Yates T, Gleeson T. Incidence and Clinical Relevance of Echocardiographic Visualization of Occult Ventricular Fibrillation: A Multicenter Prospective Study of Patients Presenting to the Emergency Department After Out-of-Hospital Cardiac Arrest. Ann Emerg Med. 2025 Oct; 86(4):328-336.
-
Lubitz SA, McConnell MV, Selvaggi C, Krishnamoorthy A, Atlas SJ, McManus DD, Pagoto S, Singer DE, Pantelopoulos A, Foulkes AS, Faranesh AZ. Wearable Irregular Heart Rhythm Detection Recurrences and Electrocardiographic Atrial Fibrillation Confirmation: The Fitbit Heart Study. Circ Arrhythm Electrophysiol. 2025 Jul; 18(7):e013565.
-
Shah SJ, Iyer JM, Agha L, Chang Y, Ashburner JM, Atlas SJ, McManus DD, Ellinor PT, Lubitz SA, Singer DE. Identifying a Heterogeneous Effect of Atrial Fibrillation Screening in Older Adults: A Secondary Analysis of the VITAL-AF Trial. Circ Cardiovasc Qual Outcomes. 2025 Jul; 18(7):e011482.
-
Wade RC, Martinez FJ, Criner GJ, Tombs L, Lipson DA, Halpin DMG, Han MK, Singh D, Wise RA, Kalhan R, Dransfield MT. ECG-based risk factors for adverse cardiopulmonary events and treatment outcomes in COPD. Eur Respir J. 2025 Feb; 65(2).
-
Sheen S, Choo J, Huh B, Chung M. The effect of oral methadone on the QTc interval in cancer pain patients. Pain Manag. 2025 Jan; 15(1):21-25.
-
Hunanyan AS, Verma A, Bidzimou MT, Biswas DD, Da Cruz E, Srour MK, Marek J, Hume C, Elmallah MK, Landstrom AP, Mikati MA. Progressive central cardiorespiratory rate downregulation and intensifying epilepsy lead to sudden unexpected death in epilepsy in mouse model of the most common human ATP1A3 mutation. Epilepsia. 2025 Mar; 66(3):899-913.
-
Shaffer BC, Brown S, Chinapen S, Mangold KE, Lahoud O, Lopez-Jimenez F, Schaffer W, Liu J, Giralt S, Devlin S, Shah G, Scordo M, Papadopoulos E, Landau H, Usmani S, Perales MA, Friedman PA, Gersh BJ, Attia IZ, Noseworthy PA, Kosmidou I. Artificial intelligence enabled interpretation of ECG images to predict hematopoietic cell transplantation toxicity. Blood Adv. 2024 11 12; 8(21):5603-5611.
-
Lopes RD, Atlas SJ, Go AS, Lubitz SA, McManus DD, Dolor RJ, Chatterjee R, Rothberg MB, Rushlow DR, Crosson LA, Aronson RS, Patlakh M, Gallup D, Mills DJ, O'Brien EC, Singer DE. Effect of Screening for Undiagnosed?Atrial Fibrillation on?Stroke?Prevention. J Am Coll Cardiol. 2024 Nov 19; 84(21):2073-2084.
-
Singer DE, Atlas SJ, Go AS, Lubitz SA, McManus DD, Dolor RJ, Chatterjee R, Rothberg MB, Rushlow DR, Crosson LA, Aronson RS, Mills D, Patlakh M, Gallup D, O'Brien EC, Lopes RD. Atrial Fibrillation Burden on a 14-Day?ECG?Monitor: Findings From the GUARD-AF Trial Screening Arm. JACC Clin Electrophysiol. 2025 Jan; 11(1):110-119.